跳至主要内容
临床试验/TCTR20210416004
TCTR20210416004Unknown2 期

asal High Flow Versus Conventional Therapy in Emergency Department Patients With Asthma Exacerbation: A Randomized Controlled Trial

Siriraj Research and Development Fund0 个研究点目标入组 80 人开始时间: 2021年4月16日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.Patients with age of 18 years or older
  • 2.Patients previously diagnosed with asthma according to GINA guideline6
  • 3.Patients who present with symptoms compatible with exacerbation according to GINA guideline6 (progressive increase in symptoms of shortness of breath, cough, wheezing or chest tightness and progressive decrease in lung function)
  • 4.Patients who are still eligible meeting the above three criteria after initial standard management for 60 minutes

排除标准

  • 1.Patients with respiratory failure; defined as respiratory rate > 35 breaths/min, SpO2 < 90% despite oxygen supplement or signs of increased work of breathing, as observed by use of accessory muscles and abdominal asynchrony.
  • 2.Patients with hemodynamic compromise (blood pressure < 90/60 mmHg) despite intravenous fluid resuscitation
  • 3.Patients with a Glasgow Coma Scale score less than 13
  • 4.Patients with contraindications to the use of equipment with positive airway pressure
  • 5.Patients previously diagnosed with COPD or other chronic lung disease such as interstitial lung disease
  • 6.Patients previously smoking > 5 pack/year
  • 7.Patients concurrently diagnosed with other lower airway conditions such as pneumonia, pulmonary edema
  • 8.Patients who decline to participate
  • 9.Pregnant patients

研究者

发起方
Siriraj Research and Development Fund

相似试验

asal High Flow Versus Conventional Therapy in... | 临床试验